Exploring the Potential of Nanopore Sequencing in Transforming Cancer Care
Technological advances in molecular biology have revolutionized the management of cancer patients, and also assisted their relatives in cases of genetic predisposition identification.
In this webinar, our expert speakers will discuss how nanopore sequencing has been applied to detect cancer predisposition genes, as well as profiling structural variants, fusions, methylation and copy number variations in cancer patients.
They will also highlight how whole genome nanopore sequencing can be used to classify medulloblastoma and provide information on subgroups, and explore how nanopore sequencing could be a game-changer for cancer care.
In this webinar, you will hear about:
- Structural variant characterization in various cancer predisposition genes using nanopore sequencing
- How nanopore adaptive sampling enables simultaneous detection of fusions, methylation and copy number profiles in pediatric brain tumors and sarcomas
- How nanopore whole genome shallow sequencing can group and subgroup medulloblastomas based on methylation profile
Speakers
Brought to you by
Now Available on Demand!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Experiencing issues viewing the form? Click here to access an alternate version
